Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

Touchefeu Y, Bailly C, Frampas E, Eugène T, Rousseau C, Bourgeois M, Bossard C, Faivre-Chauvet A, Rauscher A, Masson D, David A, Cerato E, Carlier T, Sharkey RM, Goldenberg DM, Barbet J, Kraeber-Bodere F, Bodet-Milin C

Open source

DOI: 10.1007/s00259-020-04989-3
Published: 2021 Mar
Container: European journal of nuclear medicine and molecular imaging
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00259-020-04989-3,
  title = {Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.},
  author = {Touchefeu Y and Bailly C and Frampas E and Eugène T and Rousseau C and Bourgeois M and Bossard C and Faivre-Chauvet A and Rauscher A and Masson D and David A and Cerato E and Carlier T and Sharkey RM and Goldenberg DM and Barbet J and Kraeber-Bodere F and Bodet-Milin C},
  year = {2021},
  journal = {European journal of nuclear medicine and molecular imaging},
  doi = {10.1007/s00259-020-04989-3},
  url = {https://doi.org/10.1007/s00259-020-04989-3}
}

RIS

TY  - JOUR
TI  - Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.
AU  - Touchefeu Y
AU  - Bailly C
AU  - Frampas E
AU  - Eugène T
AU  - Rousseau C
AU  - Bourgeois M
AU  - Bossard C
AU  - Faivre-Chauvet A
AU  - Rauscher A
AU  - Masson D
AU  - David A
AU  - Cerato E
AU  - Carlier T
AU  - Sharkey RM
AU  - Goldenberg DM
AU  - Barbet J
AU  - Kraeber-Bodere F
AU  - Bodet-Milin C
PY  - 2021
JO  - European journal of nuclear medicine and molecular imaging
DO  - 10.1007/s00259-020-04989-3
UR  - https://doi.org/10.1007/s00259-020-04989-3
ER  -

APA

Y, T., C, B., E, F., T, E., C, R., M, B., C, B., A, F., A, R., D, M., A, D., E, C., T, C., RM, S., DM, G., J, B., F, K., & C, B. (2021). Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-020-04989-3

Source records

pubmed · retrieved 2026-09-25T14:12:45.115Z